Popular Categories
Popular Brands
Information
Ordering
|
|
|
|


Myo-D• Stimulates Protein Synthesis
• Reduces Inflammation
• Reduces Protein Breakdown
• Reduces Body Fat
• Increases Lean Muscle Mass
Building Muscle . . .
The quality and quantity of muscle that each of us possess is essentially
controlled by protein turnover; a remodeling process that involves the
continuous synthesis (anabolism) and breakdown (catabolism) of muscle protein. A
gain in muscle mass can only occur via a reduction in the rate at which protein
is broken down or an increase in the rate of protein synthesis. However, intense
exercise causes a dramatic increase in protein turnover; both synthesis and
breakdown accelerate at equal rates. The result is a negative protein balance
and zero muscle gains from training.
Myo-D’s unique formulation is shown in research to reduce muscle breakdown and
stimulate an increase in protein synthesis. Myo-D promotes muscle gains during
intense training by enhancing not one, but the two key processes that are
essential to gaining muscle mass.
Add To Cart | Item ID | Product |
Unit Size |
List Price |
Our Price |
$200+ Orders
|
| Add |
63-0447 |
AST
Myo-D
|
120 softgels |
$38.95 |
$23.95 |
$22.75 |
All products are In Stock unless otherwise marked.
To place an order:
Add items to your Shopping Cart by clicking on "Add" above. Finished shopping? Checkout.
Display your Shopping Cart to view contents, shipping charges and options.
** The "$200+ Orders" price reflects a 5% discount for orders that total over $200.
|
|
Cart
Checkout
All AST Products
|
|
|
Other products you may be interested in
Customer Reviews
Nutrition Facts
63-0447 AST Myo-D 120 softgels
Nutrition Facts
Serving Size: 4 Softgels
Servings Per Container: 30
|
|
 |
|
|
Amount Per Serving |
% Daily Value* |
 |
|
Total Calories |
26 |
|
|
 |
|
Total Fat |
2 |
g |
3% |
 |
|
Saturated Fat |
0 |
g |
<1% |
 |
|
Polyunsaturated Fat |
1.5 |
g |
|
 |
|
Monounsaturated Fat |
0 |
g |
|
 |
|
Trans Fat |
0 |
g |
|
 |
|
Cholesterol |
0 |
mg |
0% |
 |
|
Total Carbohydrates |
1 |
g |
<1% |
 |
|
Protein |
1.2 |
g |
2% |
 |
 |
|
Average Amino Acid Profile Per Serving |
|
|
L-Leucine |
1000 |
mg |
|
|
L-Methionine |
500 |
mg |
|
|
L-Arginine |
500 |
mg |
|
 |
|
Fish Oil Concentrate |
2000 |
mg |
|
 |
|
Omega-3 Fatty Acids |
1250 |
mg |
|
 |
|
Eicosapentaenoic Acid |
1050 |
mg |
|
 |
|
Docosahexaenoic Acid |
200 |
mg |
|
 |
|
Unsaturated Fat |
1.8 |
g |
16% |
 |
 |
| *Percent Daily Values are based on a 2,000 calorie diet. |
|
| Ingredients: High ratio 5:1 EPA/DHA fish oil, ethyl ester concentrate, gelatin, leucine, glycerin, arginine, methionine powder, safflower oil, purified water, yellow beeswax, carmine dispersion, lecithin, titanium dioxide. |
|
| Recommended Use: For best results: Take 2 softgels twice daily with meals. |
|
| Warning: Contains fish and soybeans.
Manufactured in a facility that processes milk, eggs, crustacean shellfish, tree nuts, and wheat. |
|
|
Before beginning any program of weight loss, consult your health care practitioner. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
|
|
 |
|
If you notice any errors in the information above, please
let us know.
If you have further questions about this product, please contact AST at 1-800-627-2788
|
|
|
Reduce muscle breakdown!
Myo-D contains a unique 5:1 ratio of EPA:DHA which means a much more potent dose
of bioactive EPA than any other product on the market. EPA (eicosapentaenoic
acid) is the naturally occurring compound shown in research to block excessive
muscle breakdown by reducing the activity of the major biochemical pathway that
results in the destruction of muscle protein and loss of muscle mass. In
clinical studies, EPA is shown to work at the molecular level and block muscle
protein catabolism by reducing the activity of the ATP-ubiquitin-proteasome
proteolytic pathway, the major pathway of protein catabolism in muscle.
Research shows that this pathway is highly active in illnesses that promote
muscle wasting, but also active during times of calorie restriction. The
capacity of EPA to block excessive muscle protein breakdown is powerful; it’s
anti-catabolic effects are shown to be even more potent than IGF-1. If you’re
dieting to shed body fat, Myo-D could be you’re best ally. Regular use will help
you keep your hard earned muscle during dieting and contest preparation.
Stimulate muscle protein synthesis!
A high stimulation of muscle protein synthesis is essential to gaining muscle
mass, but it also underlines rapid recovery. Myo-D also contains a precision
blend of the most potent amino acids shown in research to activate protein
synthesis within muscle. Therefore, every serving of Myo-D helps to enhance
recovery and gains in muscle mass gains via two vital processes.
Firstly, Myo-D’s ultra-high concentration of bioactive EPA blocks excessive
protein breakdown. Secondly, Myo-D provides a high dose of the amino acids that
directly activate muscle protein synthesis.
In research, the formulation within Myo-D is shown to promote a greater anabolic
effect than regular EPA alone or EPA combined with protein.10 Myo-D is
scientifically formulated to reduce muscle breakdown and stimulate an increase
in protein synthesis. Therefore, Myo-D could be the most powerful,
non-prescription bodybuilding supplement available.
Reduce inflammation - speed recovery!
Inflammation is an essential part of immune activation that clears debris and
destroys pathogens. However, excessive inflammation produced by intense exercise
can result in poor recovery, chronic joint pain and muscle loss. By reducing
excess inflammation within muscle and connective tissue will provide the athlete
with a big head start in terms of recovery from exercise.
EPA is essential to the manufacture of Series-3 Prostaglandins (short lived
muscle growth factors), and Series-5 Leukotrienes (highly active immune cells)
that work to reduce muscle inflammation. Therefore, Myo-D’s 5:1 ratio of EPA
provides an ultra-high dose that helps reduce tissue inflammation and speed
recovery during intense exercise.
Improve insulin metabolism, enhance fat loss!
The cornerstone of building a lean, healthy, physique is efficient insulin
metabolism. Insulin is the hormone essential to nutrient transport into cells.
Therefore, a dietary compound that can improve insulin metabolism offers a huge
advantage for anyone attempting to shed fat or build a lean physique.
The high dose of EPA in Myo-D is shown to promote an insulin-sensitizing effect
in tissue, even in healthy people that do not have diabetes. That means more
calories are directed towards lean tissue for recovery and growth while less
calories are stores as body fat.
EPA is also known to enhance fat metabolism during exercise. Regular
supplementation with EPA appears to increase fat utilization during exercise.
Therefore, Myo-D’s 5:1 ratio of EPA provides an ultra-high dose that promotes
efficient insulin metabolism and greater fat utilization during exercise.
Myo-D promotes a high rate of muscle anabolism by minimizing protein breakdown
and stimulating protein synthesis. Regular use of Myo-D will also help improve
insulin metabolism and promote better fat loss during exercise training.
Clearly, no other dietary supplement is shown in research to provide
bodybuilders with so many important advantages that help build a lean, muscular
physique.
References:
Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA. Effect of a
fish oil-enriched nutritional supplement on metabolic mediators in patients
with pancreatic cancer cachexia. Nutr Cancer 40; 118-24, 2001.
Whitehouse AS, Tisdale MJ. Downregulation of ubiquitin-dependent proteolysis
by eicosapentaenoic acid in acute starvation. Biochem Biophys Res Commun 285;
598-602, 2001.
Barber MD. Cancer cachexia and its treatment with fish-oil-enriched
nutritional supplementation. Nutrition 2001;17:751-755.
Whitehouse AS, Smith HJ, Drake JL, Tisdale MJ. Mechanism of attenuation of
skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic
acid. Cancer Res 2001;61:3604-3609.
Stephens CB. Fish Oil and Inflammatory Disease. Nutrition Reviews 62
(12);486-489, 2004.
Bradshaw RA, Brickley WN, Walker KW. N-terminal processing: the methionine
aminopeptidase and N-alpha-acetyl transferase families. Trends Biochem Sci 23;
263,1998.
Tesseraud S, Bigot K, Toovis M Amino acid availability regulates S6K1 and
protein synthesis in avian insulin-insensitive QMT myoblasts. FEBS Lett 540;
176-181, 2003.
Vissers YLJ, von Meyenfeldt MF, Deutz MEP. Arginine production in intestine,
liver, muscle and kidney is reduced in tumour-bearing mice undergoing surgery.
Eur J Gastroenterol Hepatol 14;A59-A64., 2002.
Smith HJ, NA Greenberg and MJ Tisdale. Effect of eicosapentaenoic acid,
protein and amino acids on protein synthesis and degradation in skeletal
muscle of cachectic mice. British Journal of Cancer 91; 408-412, 2004.
Delarue J, Chang-Hong L, Richard C, Charlotte C, Brigitte S. Interaction of
fish oil and a glucocorticoid on metabolic responses to an oral glucose load
in healthy human subjects. Br J Nutr. 2006 Feb;95(2):267-72.
Hufman DM, Michaelson JL, Thomas TR. Chronic supplementation with fish oil
increases fat oxidation during exercise in young men. JEPonline. 7(1):48-56,
2004.
Kimura Y, Sumiyoshi M. Antitumor and antimetastatic actions of
eicosapentaenoic acid ethylester and its by-products formed during accelerated
stability testing. Cancer Sci. 96(7):441-50, 2005.
A Nordoy, L Barstad, WE Connor, and L Hatcher. Absorption of the n-3
eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides
by humans. Am. J. Clinical Nutrition, 53: 1185 – 1190, 1991.
Tremoli E, P Maderna, F Marangoni, S Colli, S Eligini, I Catalano, MT Angeli,
F Pazzucconi, G Gianfranceschi, and G Davi. Prolonged inhibition of platelet
aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers.
Am. J. Clinical Nutrition, 61: 607 – 613, 1995.
Grimsgaard, KH Bonaa, JB Hansen, and A Nordoy. Highly purified
eicosapentaenoic acid and docosahexaenoic acid in humans have similar
triacylglycerol-lowering effects but divergent effects on serum fatty acids.
Am. J. Clinical Nutrition, 66: 649 – 659, 1997.
|
|
|